Clinical Trials in Caserta, Italy
7 recruiting
Showing 1–16 of 16 trials
Recruiting
Phase 3
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
Heart Failure
Novo Nordisk A/S5,600 enrolled1117 locationsNCT05636176
Recruiting
Phase 3
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Hoffmann-La Roche450 enrolled210 locationsNCT06790693
Recruiting
Phase 2Phase 3
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
End-stage Kidney DiseaseAtherosclerotic Cardiovascular DiseaseAtherosclerotic Cardiovascular Disease in Patients With ESKD
CSL Behring2,310 enrolled468 locationsNCT05485961
Recruiting
Phase 3
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Gastric CancerGastroesophageal-junction CancerHER2-positive Gastric Cancer+1 more
Shanghai Henlius Biotech550 enrolled208 locationsNCT06532006
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled721 locationsNCT05712200
Recruiting
Phase 4
GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM
T2DM (Type 2 Diabetes Mellitus)
Federico II University80 enrolled2 locationsNCT07314684
Recruiting
Phase 2
ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer
Colorectal Cancer Metastatic
National Cancer Institute, Naples130 enrolled8 locationsNCT06714357
Recruiting
Phase 2Phase 3
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Karyopharm Therapeutics Inc501 enrolled57 locationsNCT04442022
Recruiting
Prevention ICONA Dedicated Ensemble
HIV-1-infectionHIVPrEP+3 more
Fondazione ICONA5,000 enrolled53 locationsNCT07186244
Recruiting
Microplastics and Nanoplastics (MNPs) in Patients With ST-elevation Myocardial Infarction (STEMI)
ST-elevation Myocardial Infarction (STEMI)MicroplasticsNanoplastics
Azienda Ospedaliera "Sant'Andrea"130 enrolled10 locationsNCT06965023
Recruiting
An Italian Multicentric Retrospective Observational Study to Assess Effectiveness and Safety of the Combination of Tafasitamab and Lenalidomide in Diffuse Large B-cell Lymphoma Patients Treated Under Named Patient Program
Diffuse Large B-Cell Lymphoma (DLBCL)
IRCCS Azienda Ospedaliero-Universitaria di Bologna96 enrolled11 locationsNCT06782789
Recruiting
Not Applicable
Integrated Approach in Frail Older People with Atrial Fibrillation
Heart FailureDiabetes MellitusHypertension+7 more
Heart Care Foundation1,250 enrolled50 locationsNCT06775028
Recruiting
Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver Cancer Development
Hepatitis C Virus Infection
Centro di Riferimento Oncologico - Aviano1,000 enrolled4 locationsNCT06718530
Recruiting
Phase 3
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
Acute Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto414 enrolled48 locationsNCT04168502
Recruiting
Not Applicable
A Multifocal TDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early Dementia
DementiaAlzheimer DiseaseAlzheimer Disease, Early Onset+3 more
University of Campania Luigi Vanvitelli50 enrolled1 locationNCT06668610
Recruiting
BRING-UP 3 Heart Failure
Heart Failure
Heart Care Foundation10,000 enrolled187 locationsNCT06279988